1. "2012"
Formats
  1. Journal Article (2365)
  2. Meeting Abstract (1182)
  3. Book Section (137)
  4. Conference Paper (23)
  5. Book Whole (10)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)

More Groups

People
  1. Clifford Hudis (64)
  2. Nancy Lee (64)
  3. Sergio Giralt (59)
  4. Robert Motzer (57)
  5. Richard Barakat (54)
  6. Howard Scher (53)

More People

Years
  1. 2012 (3719)
Publications
  1. Journal of Clinical Oncology (315)
  2. Blood (152)
  3. International Journal of Radiation Oncology, Biology, Physics (125)
  4. Cancer Research (110)
  5. Modern Pathology (80)
  6. Gynecologic Oncology (76)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (337)
  3. Springer (239)
  4. Nature Publishing Group (202)
  5. Wiley Blackwell (193)
  6. American Association for Cancer Research (192)

More Publishers

Results (3719)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular predictors for type of recurrence following conservative treatment for DCIS
    Meeting Abstract

    Sakr, R. A.; Andrade, V. P.; Chandarlapaty, S.; Giovanni, C.; Giri, D.; Heguy, A.; De Brot, M.; Olvera, N.; Muhsen, S.; Koslow, S.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • PAM50 gene signature is prognostic for breast cancer patients treated with adjuvant anthracycline and taxane based chemotherapy
    Meeting Abstract

    Liu, M. C.; Pitcher, B. N.; Mardis, E. R.; Davies, S. R.; Snider, J. E.; Vickery, T.; Reed, J. P.; DeSchryver, K.; Singh, B.; Friedman, P. N.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Work status and financial stability during treatment for early breast cancer: A pilot study of an ethnically diverse sample
    Meeting Abstract

    Eberle, C. E.; Min, S. H.; Jung, S.; Ramirez, J.; Patil, S.; Gany, F.; Blinder, V. S.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Attitudes of metastatic breast cancer patients towards research biopsies
    Meeting Abstract

    Seah, D. S.; Scott, S. M.; Najita, J.; Openshaw, T.; Krag, K. J.; Frank, E.; Sohl, J.; Stadler, Z. K.; Garrett, M.; Winer, E. P.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Prevalence and effects of off-label use of chemotherapeutic agents in elderly breast cancer patients: Estimates from Surveillance, Epidemiology and End Results Medicare data
    Meeting Abstract

    Eaton, A. A.; Sima, C. S.; Panageas, K. S.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • A randomized, phase 2 study of the poly (ADP-ribose) polymerase (PARP) inhibitor veliparib (ABT-888) in combination with temozolomide (TMZ) or in combination with carboplatin (C) and paclitaxel (P) versus placebo plus C/P in subjects with BRCA1 or BRACA2 mutation and metastatic breast cancer
    Meeting Abstract

    Isakoff, S. J.; Pulhalla, S.; Shepherd, S. P.; Falotico, N.; Kaufman, B.; Friedlander, M.; Robson, M.; Domchek, S.; Garber, J.; McKeegan, E.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • PIK3CA mutations associate with decreased Ki67 in early stage breast cancer (BC) and better outcomes in patients even among those with low Ki67 tumors
    Meeting Abstract

    Datko, F. M.; Patil, S.; Kalinsky, K.; Asher, M.; Wen, Y. H.; Hedvat, C.; Moynahan, M. E.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Limited absorption of low dose 10µg intravaginal 17-β Estradiol (Vagifem®) in postmenopausal women with breast cancer on aromatase inhibitors
    Meeting Abstract

    Goldfarb, S. B.; Dickler, M.; Dnistrian, A.; Patil, S.; Dunn, L.; Chang, K.; Berkowitz, A.; Tucker, N.; Carter, J.; Barakat, R.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Trastuzumab plus adjuvant chemotherapy for HER2-positive breast cancer: Final planned joint analysis of overall survival (OS) from NSABP B-31 and NCCTG N9831
    Meeting Abstract

    Romond, E.; Suman, V. J.; Jeong, J. H.; Sledge, G. W. Jr; Geyer, C. E. Jr; Martino, S.; Rastogi, P.; Gralow, J.; Swain, S. M.; Winer, E.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Clinical trial designs for new therapies: What endpoints should we use?
    Meeting Abstract

    Hudis, C. A.
    Cancer Research (2012)

    Fulltext@MSK | Save